Unknown OBSERVATIONAL NCT05361889

ReAl-life multIceNter Outcomes Registry for Better antithrOmbotic Strategies in Patients With AF (RAINBOW-AF)

Sponsor: Henan Provincial People's Hospital

Conditions Anticoagulant Therapy Atrial Fibrillation

Updated 4 times since 2022 Last updated: May 18, 2022 Started: Sep 30, 2022 Primary completion: Aug 31, 2025 Completion: Aug 31, 2025

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Anticoagulant Therapy and Atrial Fibrillation, this trial is ongoing. The trial is conducted by Henan Provincial People's Hospital and has accumulated 4 data snapshots since 2022. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.

Status Flow

Change History

4 versions recorded

Oct 2025 — Present [monthly]

Unknown

Status: Not Yet Recruiting → Unknown
Sep 2024 — Oct 2025 [monthly]

Not Yet Recruiting
Jul 2024 — Sep 2024 [monthly]

Not Yet Recruiting
Jun 2022 — Jul 2024 [monthly]

Not Yet Recruiting

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Henan Provincial People's Hospital

Data source: Henan Provincial People's Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.